Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Cerebral Embolic Protection in TAVR

Northwell Fellows Course 2020

A. Tariq

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Plant-based Diets for Improving Lipids

National Lipid Association

K. Williams

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Femoral Access

Northwell Fellows Course 2020

M. Kim

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

Incorporating Coronary Physiology in Decision Making

San Diego Cardiovascular Interventions (SDCI) 2017

M. Kern

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Insights from 2024 ACP Annual Meeting

D. Berg

Targeting Inflammation to Prevent Cardiovascular Disease - Ready for…

National Lipid Association

M. Garshick

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Piedmont Heart Institute

J. Burkle

Expanded Indications of Impella Protected PCI

Complex Coronary Cases

J. Lasala

Mechanical Circulatory Support: From IABP to Heart Transplant

Northwell Fellows Course 2020

H. Fernandez

Perioperative Risk Assessment & Management: When Do I Need Cardiac T…

Houston Methodist DeBakey Heart and Vascular Center

N. Faza

ASCVD Risk Assessment and Prevention: Where Do We Stand Now?

Cardiometabolic Health Congress (CMHC)

S. Virani